| [1] | Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. Jama, 2013, 310(9):948-959. |
| [2] | Doucet J,Chassagne P,Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults:a prospective study of 1000 patients[J]. J Am Geriatr Soc, 1996, 44(8):944-948. |
| [3] | Hu DY, Pan CY, Yu JM,et al. The relationship between coronary artery disease and abnormal glucose regulation in China:the China Heart Survey[J]. Eur Heart J, 2006, 27(21):2573-2579. |
| [4] | Zhu M, Li J, Li Z, et al. Mortality rates and the causes of death related to diabetes mellitus in Shanghai Songjiang District:an 11-year retrospective analysis of death certificates[J]. BMC Endocr Disord, 2015, 15:45. |
| [5] | 应令雯, 周健. 2017年ADA糖尿病医学诊疗标准解读[J]. 中国医学前沿杂志(电子版), 2017, 9(1):48-55. |
| [6] | Lien D, Mader TJ. Survival from profound alcohol-related lactic acidosis[J]. J Emerg Med,1999,17(5):841-846. |
| [7] | 中国医师协会内分泌代谢科医师分会,中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1):1-10. |
| [8] | 母义明, 杨文英, 朱大龙,等. 磺脲类药物临床应用专家共识(2016年版)[J]. 药品评价, 2017, 14(1):5-12. |
| [9] | van Giersbergen PL, Treiber A, Clozel M, et al. In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide[J]. Clin Pharmacol Ther,2002,71(4):253-262. |